Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
International Journal of Immunogenetics|September 11, 2012
HLA-A, -B, -DR allele group frequencies in 7007 kidney transplant list patients in 27 UK centresC Burt, C Cryer, S Fuggle, et al.Cancer Research|January 1, 1997
Two mechanisms of basic fibroblast growth factor-induced angiogenesis in bladder cancerT O'Brien, D Cranston, S Fuggle, et al.Cancer Research|February 1, 1995
Different angiogenic pathways characterize superficial and invasive bladder cancerT O'Brien, D Cranston, S Fuggle, et al.Cancer Research|June 1, 1996
The angiogenic factor midkine is expressed in bladder cancer, and overexpression correlates with a poor outcome in patients with invasive cancersT O'Brien, D Cranston, S Fuggle, et al.British Journal of Cancer|February 24, 2001
Human bladder cancer invasion model using rat bladder in vitro and its use to test mechanisms and therapeutic inhibitors of invasionC Fujiyama, A Jones, S Fuggle, et al.British Journal of Urology|September 1, 1995
Urinary basic fibroblast growth factor in patients with bladder cancer and benign prostatic hypertrophyT S O'Brien, K Smith, D Cranston, et al.The Journal of Urology|February 18, 1999
Urinary vascular endothelial growth factor and its correlation with bladder cancer recurrence ratesJ P Crew, T O'Brien, R Bicknell, et al.BJU International|February 15, 2000
Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancerA Jones, C Fujiyama, K Turner, et al.British Journal of Cancer|January 19, 2000
Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progressionJ P Crew, S Fuggle, R Bicknell, et al.Cancer Research|December 11, 1997
Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancerJ P Crew, T O'Brien, M Bradburn, et al.Pageof 2